HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Huang Selected Research

Percutaneous Coronary Intervention

1/2024Impacts of systemic inflammation response index on the prognosis of patients with ischemic heart failure after percutaneous coronary intervention.
10/2023Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
2/2023Red Blood Cell Distribution Width: A Risk Factor for Prognosis in Patients with Ischemic Cardiomyopathy after Percutaneous Coronary Intervention.
1/2023Impact of Stress Hyperglycemia on the Timing of Complete Revascularization in Non-diabetes Patients with ST Elevation Myocardial Infarction and Multivessel Disease.
1/2023Prognostic impacts of geriatric nutritional risk index in patients with ischemic heart failure after percutaneous coronary intervention.
1/2023Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention.
1/2022Dual Loading Antiplatelet Therapy in Patients With Acute Coronary Syndrome and High Bleeding Risk Undergoing Percutaneous Coronary Intervention: Findings From the Improving Care for Cardiovascular Disease in China Project.
1/2022De-escalation of antiplatelet therapy after percutaneous coronary intervention among East Asians and non-East Asians: a meta-analysis of randomized controlled trials.
5/2021CHA2DS2-VASc score predicts the slow flow/no-reflow phenomenon in ST-segment elevation myocardial infarction patients with multivessel disease undergoing primary percutaneous coronary intervention.
1/2020Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Huang Research Topics

Disease

340Neoplasms (Cancer)
05/2024 - 03/2002
69Breast Neoplasms (Breast Cancer)
01/2024 - 01/2005
52Inflammation (Inflammations)
05/2024 - 08/2008
48Infections
05/2024 - 12/2010
45Hypoxia (Hypoxemia)
04/2024 - 01/2007
41Neoplasm Metastasis (Metastasis)
12/2023 - 06/2003
27Hepatocellular Carcinoma (Hepatoma)
03/2024 - 03/2002
26Fibrosis (Cirrhosis)
04/2024 - 08/2000
25Osteosarcoma (Osteogenic Sarcoma)
03/2024 - 03/2005
23Myasthenia Gravis
04/2024 - 08/2008
22Leukemia
04/2024 - 03/2008
21Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 04/2016
20Carcinogenesis
01/2022 - 10/2006
19Myocardial Infarction
01/2024 - 12/2016
19Body Weight (Weight, Body)
08/2022 - 11/2007
18Insulin Resistance
05/2024 - 05/2016
18Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 08/2007
18Ovarian Neoplasms (Ovarian Cancer)
10/2023 - 03/2013
18Carcinoma (Carcinomatosis)
01/2023 - 07/2005
16Hemorrhage
05/2024 - 08/2010
16Lung Neoplasms (Lung Cancer)
01/2024 - 12/2011
16Pain (Aches)
12/2023 - 12/2007
15Sepsis (Septicemia)
01/2024 - 03/2007
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 09/2010
14Thrombosis (Thrombus)
04/2024 - 01/2017
14COVID-19
04/2024 - 01/2020
14Heart Failure
02/2024 - 06/2007
14Hypertension (High Blood Pressure)
02/2024 - 08/2009
14Stomach Neoplasms (Stomach Cancer)
03/2023 - 05/2005
13Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2024 - 05/2003
13Pancreatic Neoplasms (Pancreatic Cancer)
10/2023 - 02/2009
13Renal Cell Carcinoma (Grawitz Tumor)
04/2023 - 02/2005
12Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2024 - 11/2010
12Disease Progression
03/2024 - 06/2012
12Type 2 Diabetes Mellitus (MODY)
03/2024 - 01/2012
12Obesity
01/2024 - 08/2004
12Cognitive Dysfunction
11/2023 - 01/2017
12Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 07/2015
12Necrosis
07/2023 - 07/2010
12Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2021 - 11/2010
11Virus Diseases (Viral Diseases)
11/2022 - 01/2009
10Endometriosis
12/2023 - 03/2013
10Periodontitis
10/2023 - 10/2016
9Wounds and Injuries (Trauma)
03/2024 - 08/2012
9Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2024 - 05/2015
9Lymphoma (Lymphomas)
11/2023 - 04/2004
9Lymphatic Metastasis
01/2020 - 04/2009
8Liver Diseases (Liver Disease)
04/2024 - 12/2018

Drug/Important Bio-Agent (IBA)

105Proteins (Proteins, Gene)FDA Link
04/2024 - 03/2005
79Biomarkers (Surrogate Marker)IBA
04/2024 - 09/2005
38MicroRNAs (MicroRNA)IBA
04/2024 - 04/2010
37Messenger RNA (mRNA)IBA
12/2023 - 04/2002
28CytokinesIBA
05/2024 - 03/2008
25palbociclibIBA
01/2024 - 01/2015
25Glucose (Dextrose)FDA LinkGeneric
12/2023 - 11/2010
25Hormones (Hormone)IBA
12/2023 - 01/2012
24RNA (Ribonucleic Acid)IBA
05/2024 - 12/2014
23Sunitinib (Sutent)FDA Link
04/2023 - 10/2007
22PlatinumIBA
05/2024 - 01/2018
20Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 07/2005
19Long Noncoding RNAIBA
04/2024 - 05/2015
19Therapeutic UsesIBA
11/2023 - 07/2003
17LipidsIBA
12/2023 - 01/2011
17Cisplatin (Platino)FDA LinkGeneric
12/2023 - 02/2011
17Circular RNAIBA
12/2023 - 01/2019
16DNA (Deoxyribonucleic Acid)IBA
05/2024 - 05/2003
16EnzymesIBA
02/2024 - 05/2004
15Interleukin-6 (Interleukin 6)IBA
01/2024 - 05/2003
14CateninsIBA
04/2024 - 06/2013
14triptolideIBA
12/2023 - 01/2008
14LigandsIBA
12/2023 - 08/2007
14ErbB Receptors (EGF Receptor)IBA
12/2022 - 05/2007
13Transcription Factors (Transcription Factor)IBA
11/2023 - 12/2012
13Oxygen (Dioxygen)IBA
07/2023 - 01/2007
13Small Interfering RNA (siRNA)IBA
01/2023 - 02/2009
13salicylhydroxamic acid (SHAM)IBA
08/2022 - 10/2005
12Retinaldehyde (Retinal)IBA
01/2024 - 09/2006
12LipopolysaccharidesIBA
12/2023 - 10/2014
11Peptides (Polypeptides)IBA
03/2024 - 01/2016
10Immune Checkpoint InhibitorsIBA
05/2024 - 09/2015
10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 03/2016
10Caspase 3 (Caspase-3)IBA
11/2023 - 11/2005
10AntigensIBA
01/2023 - 02/2005
10Fulvestrant (Faslodex)FDA Link
01/2022 - 01/2018
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2024 - 05/2003
9Indicators and Reagents (Reagents)IBA
10/2023 - 05/2013
9Tyrosine Kinase InhibitorsIBA
09/2022 - 09/2009
9Estrogen ReceptorsIBA
01/2022 - 06/2007
8InterferonsIBA
05/2024 - 01/2014

Therapy/Procedure

185Therapeutics
05/2024 - 07/2003
70Drug Therapy (Chemotherapy)
05/2024 - 10/2007
28Radiotherapy
05/2024 - 04/2012
18Immunotherapy
04/2024 - 02/2005
14Percutaneous Coronary Intervention
01/2024 - 09/2016
13Ligation
10/2023 - 01/2012
11Lasers (Laser)
08/2023 - 01/2013
10Neoadjuvant Therapy
02/2023 - 02/2011
9Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2023 - 01/2014
9Length of Stay
01/2023 - 12/2007
8Precision Medicine
04/2024 - 01/2017